array:24 [
  "pii" => "S266627522100120X"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2020.09.027"
  "estado" => "S300"
  "fechaPublicacion" => "2021-07-01"
  "aid" => "379"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "sco"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621001197"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.09.009"
      "estado" => "S300"
      "fechaPublicacion" => "2021-07-01"
      "aid" => "379"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "sco"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Research Letter</span>"
        "titulo" => "Adverse events of the yellow fever vaccine in chronic urticaria&#58; evaluation of patients treated or not with omalizumab compared to healthy individuals"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "497"
            "paginaFinal" => "499"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 2290
                "Ancho" => 3333
                "Tamanyo" => 454893
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0005"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Data collection flowchart between CU patients immunized and not immunized with the Yellow Fever Vaccine &#40;YFV&#41; and healthy individuals immunized with the same vaccine&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Laura Ramos de Almeida, Roberta Fachini Criado, Paulo Ricardo Criado, Luis Felipe Ensina, Beatrice Martinez Zugaib Abdalla, Juarez Ant&#244;nio Sim&#245;es Quaresma"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Laura Ramos de"
                "apellidos" => "Almeida"
              ]
              1 => array:2 [
                "nombre" => "Roberta Fachini"
                "apellidos" => "Criado"
              ]
              2 => array:2 [
                "nombre" => "Paulo Ricardo"
                "apellidos" => "Criado"
              ]
              3 => array:2 [
                "nombre" => "Luis Felipe"
                "apellidos" => "Ensina"
              ]
              4 => array:2 [
                "nombre" => "Beatrice Martinez Zugaib"
                "apellidos" => "Abdalla"
              ]
              5 => array:2 [
                "nombre" => "Juarez Ant&#244;nio Sim&#245;es"
                "apellidos" => "Quaresma"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S266627522100120X"
          "doi" => "10.1016/j.abdp.2020.09.027"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522100120X?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001197?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009600000004/v4_202107160617/S0365059621001197/v4_202107160617/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2666275221001211"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2020.07.023"
    "estado" => "S300"
    "fechaPublicacion" => "2021-07-01"
    "aid" => "380"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
      "titulo" => "Evolu&#231;&#227;o cl&#237;nica da fun&#231;&#227;o neural em s&#233;rie de casos de neuropatia hans&#234;nica ap&#243;s neur&#243;lise ulnar"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "500"
          "paginaFinal" => "502"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Barroso&#8208;Freitas, Pedro Arthur da Rocha Ribas, Paula Frassinetti Bessa Rebello, Silmara Navarro&#8208;Pennini"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Juliana"
              "apellidos" => "Barroso&#8208;Freitas"
            ]
            1 => array:2 [
              "nombre" => "Pedro Arthur da Rocha"
              "apellidos" => "Ribas"
            ]
            2 => array:2 [
              "nombre" => "Paula Frassinetti Bessa"
              "apellidos" => "Rebello"
            ]
            3 => array:2 [
              "nombre" => "Silmara"
              "apellidos" => "Navarro&#8208;Pennini"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621001203"
        "doi" => "10.1016/j.abd.2020.07.015"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001203?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001211?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000004/v1_202107170646/S2666275221001211/v1_202107170646/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221001247"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.01.002"
    "estado" => "S300"
    "fechaPublicacion" => "2021-07-01"
    "aid" => "383"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Qual o seu diagn&#243;stico&#63;</span>"
      "titulo" => "Caso para diagn&#243;stico&#46; Les&#245;es ulceradas&#58; desafio diagn&#243;stico"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "494"
          "paginaFinal" => "496"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 762
              "Ancho" => 905
              "Tamanyo" => 113906
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">&#218;lceras na bolsa escrotal e les&#245;es acneiformes nas regi&#245;es malares&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lissi&#234; Lunardi Sbroglio, Karin Milleni de Ara&#250;jo, Bianca Passos Leite dos Santos, Alexandre Carlos Gripp"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Lissi&#234; Lunardi"
              "apellidos" => "Sbroglio"
            ]
            1 => array:2 [
              "nombre" => "Karin Milleni de"
              "apellidos" => "Ara&#250;jo"
            ]
            2 => array:2 [
              "nombre" => "Bianca Passos Leite dos"
              "apellidos" => "Santos"
            ]
            3 => array:2 [
              "nombre" => "Alexandre Carlos"
              "apellidos" => "Gripp"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621001239"
        "doi" => "10.1016/j.abd.2021.01.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001239?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001247?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000004/v1_202107170646/S2666275221001247/v1_202107170646/pt/main.assets"
  ]
  "pt" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
    "titulo" => "Eventos adversos da vacina da febre amarela em pacientes com urtic&#225;ria cr&#244;nica&#58; avalia&#231;&#227;o de doentes tratados com e sem omalizumabe e controles sadios"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Prezado Editor&#44;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "497"
        "paginaFinal" => "499"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Laura Ramos de Almeida, Roberta Fachini Criado, Paulo Ricardo Criado, Luis Felipe Ensina, Beatrice Martinez Zugaib Abdalla, Juarez Ant&#244;nio Sim&#245;es Quaresma"
        "autores" => array:6 [
          0 => array:3 [
            "nombre" => "Laura Ramos de"
            "apellidos" => "Almeida"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Roberta Fachini"
            "apellidos" => "Criado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Paulo Ricardo"
            "apellidos" => "Criado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Luis Felipe"
            "apellidos" => "Ensina"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:4 [
            "nombre" => "Beatrice Martinez Zugaib"
            "apellidos" => "Abdalla"
            "email" => array:1 [
              0 => "dra.beatrice.abdalla@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Juarez Ant&#244;nio Sim&#245;es"
            "apellidos" => "Quaresma"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Faculdade de Medicina&#44; Centro Universit&#225;rio Sa&#250;de ABC&#44; Santo Andr&#233;&#44; SP&#44; Brasil"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Divis&#227;o de Alergia&#44; Imunologia Cl&#237;nica e Reumatologia&#44; Departamento de Pediatria&#44; Universidade Federal de S&#227;o Paulo&#44; S&#227;o Paulo&#44; SP&#44; Brasil"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Centro de Ci&#234;ncias Biol&#243;gicas e da Sa&#250;de&#44; Universidade Estadual do Par&#225;&#44; Bel&#233;m&#44; PA&#44; Brasil"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2003
            "Ancho" => 2917
            "Tamanyo" => 347327
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fluxograma da coleta de dados de doentes com urtic&#225;ria cr&#244;nica imunizados e n&#227;o imunizados com a vacina da febre amarela e indiv&#237;duos sadios imunizados com a mesma vacina&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Atualmente&#44; o tratamento da urtic&#225;ria cr&#244;nica &#40;UC&#41; segue um consenso internacional&#46; Quando a UC n&#227;o responde a anti&#8208;histam&#237;nicos por at&#233; quatro semanas&#44; orienta&#8208;se o uso do omalizumabe na dose de 300<span class="elsevierStyleHsp" style=""></span>mg subcut&#226;neo &#40;SC&#41; a cada quatro semanas&#44; por pelo menos seis meses&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1&#44;2</span></a> H&#225; contraindica&#231;&#227;o formal de vacina&#231;&#227;o com v&#237;rus vivo atenuado em pacientes utilizando imunobiol&#243;gicos&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">A partir de julho de 2017&#44; no Brasil&#44; houve uma epidemia de febre amarela &#40;FA&#41;&#59; a Organiza&#231;&#227;o Mundial da Sa&#250;de &#40;OMS&#41; recomendou a imuniza&#231;&#227;o com a vacina da febre amarela &#40;VFA&#41; na dose fracionada&#44; em car&#225;ter tempor&#225;rio&#44; como estrat&#233;gia de bloqueio da doenc&#807;a&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">3&#8211;5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Como o omalizumabe age exclusivamente na IgE dos mast&#243;citos e bas&#243;filos&#44; e n&#227;o atua na imunidade celular&#44; nosso grupo recomendou a VFA em doentes com UC&#44; moradores de &#225;reas de risco para a FA&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">O presente trabalho teve como objetivo avaliar a ocorr&#234;ncia de rea&#231;&#245;es adversas &#224; VFA nos doentes com UC com e sem uso de omalizumabe e&#47;ou anti&#8208;histam&#237;nico&#46; Como objetivo secund&#225;rio&#44; foi avaliado o motivo da n&#227;o vacina&#231;&#227;o por alguns pacientes em uso de omalizumabe&#46; Conduziu&#8208;se um estudo transversal e observacional coletando os dados demogr&#225;ficos de 89 doentes com UC que estavam em seguimento no ambulat&#243;rio de urtic&#225;ria&#44; no per&#237;odo entre janeiro e abril de 2019&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Um question&#225;rio foi aplicado aos pacientes com UC e a pessoas sadias&#44; sobre eventos adversos &#224; imuniza&#231;&#227;o 30 dias ap&#243;s a vacina&#231;&#227;o&#44; e outro question&#225;rio para os doentes com UC que n&#227;o receberam a imuniza&#231;&#227;o&#44; a fim de se conhecer a motiva&#231;&#227;o que os levaram a n&#227;o receber a VFA&#46; Foram exclu&#237;dos os doentes que n&#227;o concordaram em participar do trabalho e assinar o termo de consentimento livre e esclarecido&#46; O estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa da institui&#231;&#227;o sob o n&#176; 2&#46;853&#46;158&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Os pacientes foram divididos nos seguintes grupos&#58; &#40;Grupo I&#41; 48 pacientes com UC em uso ou n&#227;o de omalizumabe&#47;anti&#8208;histam&#237;nico que receberam a VFA&#44; &#40;grupo III&#41; 41 pacientes com UC que n&#227;o receberam a VFA e &#40;grupo IIA&#41; 30 indiv&#237;duos normais &#40;sadios&#41; que fizeram uso da VFA &#40;grupo A&#41;&#46; No grupo I&#44; 48 indiv&#237;duos receberam a VFA &#8211; 30 deles estavam em uso de omalizumabe &#40;grupo B&#41;&#44; e 18 n&#227;o utilizavam omalizumabe &#40;grupo C&#44; <a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">As vari&#225;veis qualitativas foram apresentadas por frequ&#234;ncia absoluta e frequ&#234;ncia relativa&#44; e as vari&#225;veis quantitativas foram apresentadas por m&#233;dia&#44; desvio&#8208;padr&#227;o&#44; valores m&#225;ximo e m&#237;nimo&#44; mediante teste de normalidade dos dados de Shapiro&#8208;Wilk &#40;p<span class="elsevierStyleHsp" style=""></span>&#62; 0&#44;05&#41;&#46; Para comparar as vari&#225;veis qualitativas foi utilizado o teste exato de Fischer&#46; Para todas as an&#225;lises&#44; o n&#237;vel de signific&#226;ncia adotado foi &#945;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46; O programa estat&#237;stico utilizado foi Stata vers&#227;o 1&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Foram aplicados question&#225;rios aos 89 pacientes com UC&#44; e aos 30 indiv&#237;duos sadios que receberam a VFA &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a> est&#227;o os resultados dos dados demogr&#225;ficos&#44; subtipos de UC e tratamento dos pacientes inclu&#237;dos no estudo no per&#237;odo entre janeiro e abril de 2019&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">Dos pacientes com UC&#44; 48 &#40;53&#44;93&#37;&#41; receberam a VFA concomitante ao tratamento e 41 &#40;46&#44;07&#37;&#41; n&#227;o a receberam&#46; Todos os 48 pacientes que tomaram a VFA responderam ao question&#225;rio sobre rea&#231;&#245;es adversas&#46; A maioria dos pacientes &#40;89&#44;58&#37;&#41; n&#227;o referiu nenhuma rea&#231;&#227;o adversa &#224; vacina&#44; em concomit&#226;ncia com o tratamento com o omalizamabe&#46; Foram relatados tr&#234;s &#40;6&#44;25&#37;&#41; casos com rea&#231;&#227;o local &#224; aplica&#231;&#227;o da VFA&#44; um &#40;2&#44;08&#37;&#41; de astenia e um &#40;2&#44;08&#37;&#41; com exacerba&#231;&#227;o da doen&#231;a apresentando angioedema&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Ao grupo de pacientes com UC que respondeu n&#227;o ter tomado voluntariamente a VFA&#44; a maioria &#40;31&#44;71&#37;&#41; n&#227;o procurou a imuniza&#231;&#227;o em virtude de j&#225; ter sido imunizado anteriormente ao tratamento da UC&#59; 26&#44;83&#37; referiram &#8220;Foi informado que n&#227;o deveria tomar por causa do tratamento por outro profissional da sa&#250;de&#8221;&#59; 21&#44;95&#37; referiram &#8220;Decidiu n&#227;o tomar&#8221;&#59; 12&#44;20&#37; tiveram &#8220;Receio de tomar a vacina devido &#224; doen&#231;a&#8221;&#46; Os demais pacientes responderam ao question&#225;rio com as seguintes afirma&#231;&#245;es&#58; &#8220;N&#227;o teve tempo&#44; orientado a n&#227;o tomar a vacina por causa de cirurgia bari&#225;trica&#8221; e &#8220;Orientada a n&#227;o tomar a vacina devido &#224; gravidez&#8221; &#8211; cada resposta destas compreendeu 2&#44;44&#37; das respostas&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Na <a class="elsevierStyleCrossRef" href="#tbl0010">tabela 2</a> encontram&#8208;se descritos os eventos adversos em 30 indiv&#237;duos sadios&#44; 30 doentes com UC tratados com omalizumabe e 18 doentes com UC sem uso de omalizumabe&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">A an&#225;lise estat&#237;stica&#44; utilizando o teste exato de Fischer&#44; n&#227;o demonstrou diferen&#231;as entre a presen&#231;a ou n&#227;o de rea&#231;&#245;es adversas entre os grupos A &#40;indiv&#237;duos sadios&#41;&#44; B &#40;doentes com UC tratados com omalizumabe&#41; e C &#40;doentes com UC sem uso de omalizumabe&#41;&#44; com p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;553&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">N&#227;o h&#225; relatos na literatura a respeito do uso de omalizumabe concomitante &#224; imuniza&#231;&#227;o contra a FA&#46; A imuniza&#231;&#227;o contra a FA nos pacientes com UC em uso de omalizumabe foi aconselhada&#44; pois as rea&#231;&#245;es mediadas pela IgE&#44; nos mast&#243;citos e bas&#243;filos&#44; n&#227;o s&#227;o cruciais ao combate de infec&#231;&#245;es virais&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Apenas tr&#234;s pacientes &#40;6&#44;25&#37;&#41; mencionaram rea&#231;&#227;o cut&#226;nea no local da aplica&#231;&#227;o da vacina&#46; A frequ&#234;ncia desse evento &#233; de 4&#37; na popula&#231;&#227;o que recebe a VFA&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a> Um indiv&#237;duo &#40;2&#44;08&#37;&#41; referiu astenia&#46; A ocorr&#234;ncia de manifesta&#231;&#227;o sist&#234;mica &#233; de 1&#37; a 6&#37; dos indiv&#237;duos&#46; Por fim&#44; um paciente &#40;2&#44;08&#37;&#41; referiu exacerba&#231;&#227;o do angioedema ao tomar a vacina&#44; o que pode estar ligado tanto a uma poss&#237;vel rea&#231;&#227;o &#224; VFA quanto &#224; flutua&#231;&#227;o na atividade do controle da urtic&#225;ria em tratamento&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Comparando&#8208;se os grupos doentes em uso do omalizumabe que tomaram a VFA e doentes com UC sem omalizumabe que tomaram a VFA&#44; n&#227;o houve diferen&#231;a estat&#237;stica&#46; No grupo controle das 30 pessoas sadias comparando&#8208;se aos 30 doentes com UC que faziam uso do omalizumabe e tomaram a VFA tamb&#233;m n&#227;o se observou diferen&#231;a estat&#237;stica em rela&#231;&#227;o aos efeitos adversos&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Nosso estudo mostrou que os doentes com UC em tratamento com anti&#8208;histam&#237;nicos e&#47;ou omalizumabe n&#227;o referiram eventos adversos ap&#243;s a imuniza&#231;&#227;o contra a FA&#44; quando comparados aos indiv&#237;duos sadios&#44; sem UC&#44; que receberam a imuniza&#231;&#227;o no mesmo per&#237;odo&#44; com a mesma vacina fornecida pelo Minist&#233;rio da Sa&#250;de do Brasil&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Suporte financeiro</span><p id="par0085" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Contribui&#231;&#227;o dos autores</span><p id="par0090" class="elsevierStylePara elsevierViewall">Laura Ramos de Almeida&#58; An&#225;lise estat&#237;stica&#59; elabora&#231;&#227;o e reda&#231;&#227;o do manuscrito&#59; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">Roberta Fachini Criado&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; participa&#231;&#227;o efetiva na orienta&#231;&#227;o da pesquisa&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Paulo Ricardo Criado&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; participa&#231;&#227;o efetiva na orienta&#231;&#227;o da pesquisa&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">Luis Felipe Ensina&#58; An&#225;lise estat&#237;stica&#59; aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; revis&#227;o cr&#237;tica da literatura&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Beatrice Martinez Zugaib Abdalla&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; elabora&#231;&#227;o e reda&#231;&#227;o do manuscrito&#59; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; revis&#227;o cr&#237;tica da literatura&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">Juarez Ant&#244;nio Sim&#245;es Quaresma&#58; An&#225;lise estat&#237;stica&#59; aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; revis&#227;o cr&#237;tica da literatura&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflito de interesses</span><p id="par0120" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Suporte financeiro"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Contribui&#231;&#227;o dos autores"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflito de interesses"
        ]
        3 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-06-14"
    "fechaAceptado" => "2020-09-03"
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Almeida LR&#44; Criado RF&#44; Criado PR&#44; Ensina LF&#44; Abdalla BMZ&#44; Quaresma JAS&#46; Adverse events of the yellow fever vaccine in chronic urticaria&#58; evaluation of patients treated or not with omalizumab compared to healthy individuals&#46; An Bras Dermatol&#46; 2021&#59;96&#58;497&#8211;9&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado na Faculdade de Medicina do ABC&#44; Santo Andr&#233;&#44; SP&#44; Brasil&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2003
            "Ancho" => 2917
            "Tamanyo" => 347327
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fluxograma da coleta de dados de doentes com urtic&#225;ria cr&#244;nica imunizados e n&#227;o imunizados com a vacina da febre amarela e indiv&#237;duos sadios imunizados com a mesma vacina&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">UC&#44; urtic&#225;ria cr&#244;nica&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caracter&#237;sticas dos doentes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Frequ&#234;ncia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">G&#234;nero</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16&#44;85&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Feminino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">74&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">83&#44;15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Classifica&#231;&#227;o da urtic&#225;ria</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">71&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">79&#44;78&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCindu&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;49&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCE &#43; UCind&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">14&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15&#44;73&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Manifesta&#231;&#245;es cl&#237;nicas</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UC &#43; angiodema&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">63&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">70&#44;79&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UC isolado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;09&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Angiodema isolado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Uso de omalizumabe</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>N&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">35&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">39&#44;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Sim&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">54&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Tomou a vacina de febre amarela&#63;</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>N&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">46&#44;07&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Sim&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">48&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">53&#44;93&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2658516.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Dados demogr&#225;ficos&#44; tipo de urtic&#225;ria&#44; uso do omalizumabe e imuniza&#231;&#227;o contra a febre amarela entre os 89 doentes com urtic&#225;ria participantes do estudo</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabela 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">Grupos de indiv&#237;duos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="5" align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rea&#231;&#245;es adversas atribu&#237;das &#224; vacina contra febre amarela</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Nenhuma&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rea&#231;&#227;o cut&#226;nea local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Astenia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Exacerba&#231;&#227;o do angioedema&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Febre&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25 &#40;83&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;10&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;6&#44;67&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo B&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27 &#40;90&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo C&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16 &#40;88&#44;89&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;11&#44;11&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">68 &#40;87&#44;18&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;7&#44;69&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;1&#44;28&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;1&#44;28&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;2&#44;56&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">78 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2658515.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Compara&#231;&#227;o entre o relato de rea&#231;&#245;es adversas atribu&#237;das &#224; vacina&#231;&#227;o contra a febre amarela&#44; entre indiv&#237;duos sadios &#40;grupo A&#41;&#44; doentes com urtic&#225;ria cr&#244;nica tratados com omalizumabe &#40;grupo B&#41; doentes com urtic&#225;ria cr&#244;nica sem uso de omalizumabe &#40;grupo C&#41;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => """
                    Brasil&#46; Minist&#233;rio da Sa&#250;de&#46; Minist&#233;rio da Sa&#250;de divulga balan&#231;o de um ano da febre amarela &#91;Internet&#93;&#46; 2018 Dez&#46; 8 &#91;cited 2018 Dez 27&#93;&#46; Dispon&#237;vel em&#58; \n
                    <https: www.gov.br="" aude="" t&#8208;br="" ssuntos="" oticias="" inisterio&#8208;da&#8208;saude&#8208;divulga&#8208;balanco&#8208;de&#8208;um&#8208;ano&#8208;da&#8208;febre&#8208;amarela="">\n
                     &#46;\n
                    </https:>
                    """
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Chronic urticaria in adults&#58; state&#8208;of&#8208;the&#8208;art in the new millennium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46;R&#46; Criado"
                            1 => "R&#46;F&#46;J&#46; Criado"
                            2 => "C&#46;W&#46; Maruta"
                            3 => "V&#46;M&#46;S&#46; Reis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/abd1806-4841.20153509"
                      "Revista" => array:6 [
                        "tituloSerie" => "An Bras Dermatol&#46;"
                        "fecha" => "2015"
                        "volumen" => "90"
                        "paginaInicial" => "74"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25672302"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Sociedade Brasileira de Infectologia&#46; &#91;Internet&#93;&#46; Vacina contra febre amarela informativo para profissionais de sa&#250;de &#91;Internet&#93;&#46; 2018 Jan 30 &#91;cited 2019 Jan 3&#93;&#46; Dispon&#237;vel em&#58; www&#46;infectologia&#46;org&#46;br&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fractional&#8208;dose yellow fever vaccination&#58; how much more can we do with less&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "L&#46;G&#46; Visser"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/QCO.0000000000000576"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Infect Dis&#46;"
                        "fecha" => "2019"
                        "volumen" => "32"
                        "paginaInicial" => "390"
                        "paginaFinal" => "393"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31335440"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => """
                    Brasil&#46; Minist&#233;rio da Sa&#250;de&#46; Contraindica&#231;&#245;es para a Vacina de Febre Amarela &#91;Internet&#93;&#46; &#91;cited 2019 Mar 23&#93;&#46; Dispon&#237;vel em&#58; \n
                    <www.saude.gov.br>\n
                     &#46;\n
                    </www.saude.gov.br>
                    """
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serious adverse events associated with yellow fever vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Menezes Martins"
                            1 => "M&#46;L&#46; Fernandes Leal"
                            2 => "A&#46; Homma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/21645515.2015.1022700"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hum Vaccin Immunother&#46;"
                        "fecha" => "2015"
                        "volumen" => "11"
                        "paginaInicial" => "2183"
                        "paginaFinal" => "2187"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26090855"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009600000004/v1_202107170646/S266627522100120X/v1_202107170646/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "82068"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Carta - Investiga&#231;&#227;o"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009600000004/v1_202107170646/S266627522100120X/v1_202107170646/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522100120X?idApp=UINPBA00008Z"
]
Compartilhar
Informação da revista

Estatísticas

Siga este link para acessar o texto completo do artigo

Carta ‐ Investigação
Eventos adversos da vacina da febre amarela em pacientes com urticária crônica: avaliação de doentes tratados com e sem omalizumabe e controles sadios
Laura Ramos de Almeidaa, Roberta Fachini Criadoa, Paulo Ricardo Criadoa, Luis Felipe Ensinab, Beatrice Martinez Zugaib Abdallaa,
Autor para correspondência
dra.beatrice.abdalla@gmail.com

Autor para correspondência.
, Juarez Antônio Simões Quaresmac
a Faculdade de Medicina, Centro Universitário Saúde ABC, Santo André, SP, Brasil
b Divisão de Alergia, Imunologia Clínica e Reumatologia, Departamento de Pediatria, Universidade Federal de São Paulo, São Paulo, SP, Brasil
c Centro de Ciências Biológicas e da Saúde, Universidade Estadual do Pará, Belém, PA, Brasil
Lido
6031
Vezes
que se leu este artigo
2524
Total PDF
3507
Total HTML
Compartilhar estatísticas
 array:24 [
  "pii" => "S266627522100120X"
  "issn" => "26662752"
  "doi" => "10.1016/j.abdp.2020.09.027"
  "estado" => "S300"
  "fechaPublicacion" => "2021-07-01"
  "aid" => "379"
  "copyright" => "Sociedade Brasileira de Dermatologia"
  "copyrightAnyo" => "2021"
  "documento" => "article"
  "crossmark" => 1
  "licencia" => "http://creativecommons.org/licenses/by/4.0/"
  "subdocumento" => "sco"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:1 [
    "total" => 0
  ]
  "Traduccion" => array:1 [
    "en" => array:19 [
      "pii" => "S0365059621001197"
      "issn" => "03650596"
      "doi" => "10.1016/j.abd.2020.09.009"
      "estado" => "S300"
      "fechaPublicacion" => "2021-07-01"
      "aid" => "379"
      "copyright" => "Sociedade Brasileira de Dermatologia"
      "documento" => "article"
      "crossmark" => 1
      "licencia" => "http://creativecommons.org/licenses/by/4.0/"
      "subdocumento" => "sco"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:1 [
        "total" => 0
      ]
      "en" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Research Letter</span>"
        "titulo" => "Adverse events of the yellow fever vaccine in chronic urticaria&#58; evaluation of patients treated or not with omalizumab compared to healthy individuals"
        "tienePdf" => "en"
        "tieneTextoCompleto" => "en"
        "paginas" => array:1 [
          0 => array:2 [
            "paginaInicial" => "497"
            "paginaFinal" => "499"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "en" => true
        ]
        "contienePdf" => array:1 [
          "en" => true
        ]
        "resumenGrafico" => array:2 [
          "original" => 0
          "multimedia" => array:8 [
            "identificador" => "fig0005"
            "etiqueta" => "Figure 1"
            "tipo" => "MULTIMEDIAFIGURA"
            "mostrarFloat" => true
            "mostrarDisplay" => false
            "figura" => array:1 [
              0 => array:4 [
                "imagen" => "gr1.jpeg"
                "Alto" => 2290
                "Ancho" => 3333
                "Tamanyo" => 454893
              ]
            ]
            "detalles" => array:1 [
              0 => array:3 [
                "identificador" => "at0005"
                "detalle" => "Figure "
                "rol" => "short"
              ]
            ]
            "descripcion" => array:1 [
              "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Data collection flowchart between CU patients immunized and not immunized with the Yellow Fever Vaccine &#40;YFV&#41; and healthy individuals immunized with the same vaccine&#46;</p>"
            ]
          ]
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "Laura Ramos de Almeida, Roberta Fachini Criado, Paulo Ricardo Criado, Luis Felipe Ensina, Beatrice Martinez Zugaib Abdalla, Juarez Ant&#244;nio Sim&#245;es Quaresma"
            "autores" => array:6 [
              0 => array:2 [
                "nombre" => "Laura Ramos de"
                "apellidos" => "Almeida"
              ]
              1 => array:2 [
                "nombre" => "Roberta Fachini"
                "apellidos" => "Criado"
              ]
              2 => array:2 [
                "nombre" => "Paulo Ricardo"
                "apellidos" => "Criado"
              ]
              3 => array:2 [
                "nombre" => "Luis Felipe"
                "apellidos" => "Ensina"
              ]
              4 => array:2 [
                "nombre" => "Beatrice Martinez Zugaib"
                "apellidos" => "Abdalla"
              ]
              5 => array:2 [
                "nombre" => "Juarez Ant&#244;nio Sim&#245;es"
                "apellidos" => "Quaresma"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "en"
      "Traduccion" => array:1 [
        "pt" => array:9 [
          "pii" => "S266627522100120X"
          "doi" => "10.1016/j.abdp.2020.09.027"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "pt"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522100120X?idApp=UINPBA00008Z"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001197?idApp=UINPBA00008Z"
      "url" => "/03650596/0000009600000004/v4_202107160617/S0365059621001197/v4_202107160617/en/main.assets"
    ]
  ]
  "itemSiguiente" => array:18 [
    "pii" => "S2666275221001211"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2020.07.023"
    "estado" => "S300"
    "fechaPublicacion" => "2021-07-01"
    "aid" => "380"
    "documento" => "article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "sco"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:9 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
      "titulo" => "Evolu&#231;&#227;o cl&#237;nica da fun&#231;&#227;o neural em s&#233;rie de casos de neuropatia hans&#234;nica ap&#243;s neur&#243;lise ulnar"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "500"
          "paginaFinal" => "502"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Juliana Barroso&#8208;Freitas, Pedro Arthur da Rocha Ribas, Paula Frassinetti Bessa Rebello, Silmara Navarro&#8208;Pennini"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Juliana"
              "apellidos" => "Barroso&#8208;Freitas"
            ]
            1 => array:2 [
              "nombre" => "Pedro Arthur da Rocha"
              "apellidos" => "Ribas"
            ]
            2 => array:2 [
              "nombre" => "Paula Frassinetti Bessa"
              "apellidos" => "Rebello"
            ]
            3 => array:2 [
              "nombre" => "Silmara"
              "apellidos" => "Navarro&#8208;Pennini"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621001203"
        "doi" => "10.1016/j.abd.2020.07.015"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001203?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001211?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000004/v1_202107170646/S2666275221001211/v1_202107170646/pt/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S2666275221001247"
    "issn" => "26662752"
    "doi" => "10.1016/j.abdp.2021.01.002"
    "estado" => "S300"
    "fechaPublicacion" => "2021-07-01"
    "aid" => "383"
    "copyright" => "Sociedade Brasileira de Dermatologia"
    "documento" => "simple-article"
    "crossmark" => 1
    "licencia" => "http://creativecommons.org/licenses/by/4.0/"
    "subdocumento" => "crp"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:1 [
      "total" => 0
    ]
    "pt" => array:12 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Qual o seu diagn&#243;stico&#63;</span>"
      "titulo" => "Caso para diagn&#243;stico&#46; Les&#245;es ulceradas&#58; desafio diagn&#243;stico"
      "tienePdf" => "pt"
      "tieneTextoCompleto" => "pt"
      "tieneResumen" => "pt"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "494"
          "paginaFinal" => "496"
        ]
      ]
      "contieneResumen" => array:1 [
        "pt" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "pt" => true
      ]
      "contienePdf" => array:1 [
        "pt" => true
      ]
      "resumenGrafico" => array:2 [
        "original" => 0
        "multimedia" => array:7 [
          "identificador" => "fig0015"
          "etiqueta" => "Figura 3"
          "tipo" => "MULTIMEDIAFIGURA"
          "mostrarFloat" => true
          "mostrarDisplay" => false
          "figura" => array:1 [
            0 => array:4 [
              "imagen" => "gr3.jpeg"
              "Alto" => 762
              "Ancho" => 905
              "Tamanyo" => 113906
            ]
          ]
          "descripcion" => array:1 [
            "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">&#218;lceras na bolsa escrotal e les&#245;es acneiformes nas regi&#245;es malares&#46;</p>"
          ]
        ]
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Lissi&#234; Lunardi Sbroglio, Karin Milleni de Ara&#250;jo, Bianca Passos Leite dos Santos, Alexandre Carlos Gripp"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Lissi&#234; Lunardi"
              "apellidos" => "Sbroglio"
            ]
            1 => array:2 [
              "nombre" => "Karin Milleni de"
              "apellidos" => "Ara&#250;jo"
            ]
            2 => array:2 [
              "nombre" => "Bianca Passos Leite dos"
              "apellidos" => "Santos"
            ]
            3 => array:2 [
              "nombre" => "Alexandre Carlos"
              "apellidos" => "Gripp"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "pt"
    "Traduccion" => array:1 [
      "en" => array:9 [
        "pii" => "S0365059621001239"
        "doi" => "10.1016/j.abd.2021.01.002"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "en"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0365059621001239?idApp=UINPBA00008Z"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2666275221001247?idApp=UINPBA00008Z"
    "url" => "/26662752/0000009600000004/v1_202107170646/S2666275221001247/v1_202107170646/pt/main.assets"
  ]
  "pt" => array:17 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Carta &#8208; Investiga&#231;&#227;o</span>"
    "titulo" => "Eventos adversos da vacina da febre amarela em pacientes com urtic&#225;ria cr&#244;nica&#58; avalia&#231;&#227;o de doentes tratados com e sem omalizumabe e controles sadios"
    "tieneTextoCompleto" => true
    "saludo" => "<span class="elsevierStyleItalic">Prezado Editor&#44;</span>"
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "497"
        "paginaFinal" => "499"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Laura Ramos de Almeida, Roberta Fachini Criado, Paulo Ricardo Criado, Luis Felipe Ensina, Beatrice Martinez Zugaib Abdalla, Juarez Ant&#244;nio Sim&#245;es Quaresma"
        "autores" => array:6 [
          0 => array:3 [
            "nombre" => "Laura Ramos de"
            "apellidos" => "Almeida"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Roberta Fachini"
            "apellidos" => "Criado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          2 => array:3 [
            "nombre" => "Paulo Ricardo"
            "apellidos" => "Criado"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
            ]
          ]
          3 => array:3 [
            "nombre" => "Luis Felipe"
            "apellidos" => "Ensina"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">b</span>"
                "identificador" => "aff0010"
              ]
            ]
          ]
          4 => array:4 [
            "nombre" => "Beatrice Martinez Zugaib"
            "apellidos" => "Abdalla"
            "email" => array:1 [
              0 => "dra.beatrice.abdalla@gmail.com"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">a</span>"
                "identificador" => "aff0005"
              ]
              1 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">&#42;</span>"
                "identificador" => "cor0005"
              ]
            ]
          ]
          5 => array:3 [
            "nombre" => "Juarez Ant&#244;nio Sim&#245;es"
            "apellidos" => "Quaresma"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">c</span>"
                "identificador" => "aff0015"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:3 [
          0 => array:3 [
            "entidad" => "Faculdade de Medicina&#44; Centro Universit&#225;rio Sa&#250;de ABC&#44; Santo Andr&#233;&#44; SP&#44; Brasil"
            "etiqueta" => "a"
            "identificador" => "aff0005"
          ]
          1 => array:3 [
            "entidad" => "Divis&#227;o de Alergia&#44; Imunologia Cl&#237;nica e Reumatologia&#44; Departamento de Pediatria&#44; Universidade Federal de S&#227;o Paulo&#44; S&#227;o Paulo&#44; SP&#44; Brasil"
            "etiqueta" => "b"
            "identificador" => "aff0010"
          ]
          2 => array:3 [
            "entidad" => "Centro de Ci&#234;ncias Biol&#243;gicas e da Sa&#250;de&#44; Universidade Estadual do Par&#225;&#44; Bel&#233;m&#44; PA&#44; Brasil"
            "etiqueta" => "c"
            "identificador" => "aff0015"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor0005"
            "etiqueta" => "&#8270;"
            "correspondencia" => "Autor para correspond&#234;ncia&#46;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2003
            "Ancho" => 2917
            "Tamanyo" => 347327
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fluxograma da coleta de dados de doentes com urtic&#225;ria cr&#244;nica imunizados e n&#227;o imunizados com a vacina da febre amarela e indiv&#237;duos sadios imunizados com a mesma vacina&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Atualmente&#44; o tratamento da urtic&#225;ria cr&#244;nica &#40;UC&#41; segue um consenso internacional&#46; Quando a UC n&#227;o responde a anti&#8208;histam&#237;nicos por at&#233; quatro semanas&#44; orienta&#8208;se o uso do omalizumabe na dose de 300<span class="elsevierStyleHsp" style=""></span>mg subcut&#226;neo &#40;SC&#41; a cada quatro semanas&#44; por pelo menos seis meses&#46;<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">1&#44;2</span></a> H&#225; contraindica&#231;&#227;o formal de vacina&#231;&#227;o com v&#237;rus vivo atenuado em pacientes utilizando imunobiol&#243;gicos&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">A partir de julho de 2017&#44; no Brasil&#44; houve uma epidemia de febre amarela &#40;FA&#41;&#59; a Organiza&#231;&#227;o Mundial da Sa&#250;de &#40;OMS&#41; recomendou a imuniza&#231;&#227;o com a vacina da febre amarela &#40;VFA&#41; na dose fracionada&#44; em car&#225;ter tempor&#225;rio&#44; como estrat&#233;gia de bloqueio da doenc&#807;a&#46;<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">3&#8211;5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Como o omalizumabe age exclusivamente na IgE dos mast&#243;citos e bas&#243;filos&#44; e n&#227;o atua na imunidade celular&#44; nosso grupo recomendou a VFA em doentes com UC&#44; moradores de &#225;reas de risco para a FA&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a></p><p id="par0020" class="elsevierStylePara elsevierViewall">O presente trabalho teve como objetivo avaliar a ocorr&#234;ncia de rea&#231;&#245;es adversas &#224; VFA nos doentes com UC com e sem uso de omalizumabe e&#47;ou anti&#8208;histam&#237;nico&#46; Como objetivo secund&#225;rio&#44; foi avaliado o motivo da n&#227;o vacina&#231;&#227;o por alguns pacientes em uso de omalizumabe&#46; Conduziu&#8208;se um estudo transversal e observacional coletando os dados demogr&#225;ficos de 89 doentes com UC que estavam em seguimento no ambulat&#243;rio de urtic&#225;ria&#44; no per&#237;odo entre janeiro e abril de 2019&#46;</p><p id="par0025" class="elsevierStylePara elsevierViewall">Um question&#225;rio foi aplicado aos pacientes com UC e a pessoas sadias&#44; sobre eventos adversos &#224; imuniza&#231;&#227;o 30 dias ap&#243;s a vacina&#231;&#227;o&#44; e outro question&#225;rio para os doentes com UC que n&#227;o receberam a imuniza&#231;&#227;o&#44; a fim de se conhecer a motiva&#231;&#227;o que os levaram a n&#227;o receber a VFA&#46; Foram exclu&#237;dos os doentes que n&#227;o concordaram em participar do trabalho e assinar o termo de consentimento livre e esclarecido&#46; O estudo foi aprovado pelo Comit&#234; de &#201;tica em Pesquisa da institui&#231;&#227;o sob o n&#176; 2&#46;853&#46;158&#46;</p><p id="par0030" class="elsevierStylePara elsevierViewall">Os pacientes foram divididos nos seguintes grupos&#58; &#40;Grupo I&#41; 48 pacientes com UC em uso ou n&#227;o de omalizumabe&#47;anti&#8208;histam&#237;nico que receberam a VFA&#44; &#40;grupo III&#41; 41 pacientes com UC que n&#227;o receberam a VFA e &#40;grupo IIA&#41; 30 indiv&#237;duos normais &#40;sadios&#41; que fizeram uso da VFA &#40;grupo A&#41;&#46; No grupo I&#44; 48 indiv&#237;duos receberam a VFA &#8211; 30 deles estavam em uso de omalizumabe &#40;grupo B&#41;&#44; e 18 n&#227;o utilizavam omalizumabe &#40;grupo C&#44; <a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46;</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0035" class="elsevierStylePara elsevierViewall">As vari&#225;veis qualitativas foram apresentadas por frequ&#234;ncia absoluta e frequ&#234;ncia relativa&#44; e as vari&#225;veis quantitativas foram apresentadas por m&#233;dia&#44; desvio&#8208;padr&#227;o&#44; valores m&#225;ximo e m&#237;nimo&#44; mediante teste de normalidade dos dados de Shapiro&#8208;Wilk &#40;p<span class="elsevierStyleHsp" style=""></span>&#62; 0&#44;05&#41;&#46; Para comparar as vari&#225;veis qualitativas foi utilizado o teste exato de Fischer&#46; Para todas as an&#225;lises&#44; o n&#237;vel de signific&#226;ncia adotado foi &#945;<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;05&#46; O programa estat&#237;stico utilizado foi Stata vers&#227;o 1&#46;</p><p id="par0040" class="elsevierStylePara elsevierViewall">Foram aplicados question&#225;rios aos 89 pacientes com UC&#44; e aos 30 indiv&#237;duos sadios que receberam a VFA &#40;<a class="elsevierStyleCrossRef" href="#fig0005">fig&#46; 1</a>&#41;&#46; Na <a class="elsevierStyleCrossRef" href="#tbl0005">tabela 1</a> est&#227;o os resultados dos dados demogr&#225;ficos&#44; subtipos de UC e tratamento dos pacientes inclu&#237;dos no estudo no per&#237;odo entre janeiro e abril de 2019&#46;</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0045" class="elsevierStylePara elsevierViewall">Dos pacientes com UC&#44; 48 &#40;53&#44;93&#37;&#41; receberam a VFA concomitante ao tratamento e 41 &#40;46&#44;07&#37;&#41; n&#227;o a receberam&#46; Todos os 48 pacientes que tomaram a VFA responderam ao question&#225;rio sobre rea&#231;&#245;es adversas&#46; A maioria dos pacientes &#40;89&#44;58&#37;&#41; n&#227;o referiu nenhuma rea&#231;&#227;o adversa &#224; vacina&#44; em concomit&#226;ncia com o tratamento com o omalizamabe&#46; Foram relatados tr&#234;s &#40;6&#44;25&#37;&#41; casos com rea&#231;&#227;o local &#224; aplica&#231;&#227;o da VFA&#44; um &#40;2&#44;08&#37;&#41; de astenia e um &#40;2&#44;08&#37;&#41; com exacerba&#231;&#227;o da doen&#231;a apresentando angioedema&#46;</p><p id="par0050" class="elsevierStylePara elsevierViewall">Ao grupo de pacientes com UC que respondeu n&#227;o ter tomado voluntariamente a VFA&#44; a maioria &#40;31&#44;71&#37;&#41; n&#227;o procurou a imuniza&#231;&#227;o em virtude de j&#225; ter sido imunizado anteriormente ao tratamento da UC&#59; 26&#44;83&#37; referiram &#8220;Foi informado que n&#227;o deveria tomar por causa do tratamento por outro profissional da sa&#250;de&#8221;&#59; 21&#44;95&#37; referiram &#8220;Decidiu n&#227;o tomar&#8221;&#59; 12&#44;20&#37; tiveram &#8220;Receio de tomar a vacina devido &#224; doen&#231;a&#8221;&#46; Os demais pacientes responderam ao question&#225;rio com as seguintes afirma&#231;&#245;es&#58; &#8220;N&#227;o teve tempo&#44; orientado a n&#227;o tomar a vacina por causa de cirurgia bari&#225;trica&#8221; e &#8220;Orientada a n&#227;o tomar a vacina devido &#224; gravidez&#8221; &#8211; cada resposta destas compreendeu 2&#44;44&#37; das respostas&#46;</p><p id="par0055" class="elsevierStylePara elsevierViewall">Na <a class="elsevierStyleCrossRef" href="#tbl0010">tabela 2</a> encontram&#8208;se descritos os eventos adversos em 30 indiv&#237;duos sadios&#44; 30 doentes com UC tratados com omalizumabe e 18 doentes com UC sem uso de omalizumabe&#46;</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia><p id="par0060" class="elsevierStylePara elsevierViewall">A an&#225;lise estat&#237;stica&#44; utilizando o teste exato de Fischer&#44; n&#227;o demonstrou diferen&#231;as entre a presen&#231;a ou n&#227;o de rea&#231;&#245;es adversas entre os grupos A &#40;indiv&#237;duos sadios&#41;&#44; B &#40;doentes com UC tratados com omalizumabe&#41; e C &#40;doentes com UC sem uso de omalizumabe&#41;&#44; com p<span class="elsevierStyleHsp" style=""></span>&#61;<span class="elsevierStyleHsp" style=""></span>0&#44;553&#46;</p><p id="par0065" class="elsevierStylePara elsevierViewall">N&#227;o h&#225; relatos na literatura a respeito do uso de omalizumabe concomitante &#224; imuniza&#231;&#227;o contra a FA&#46; A imuniza&#231;&#227;o contra a FA nos pacientes com UC em uso de omalizumabe foi aconselhada&#44; pois as rea&#231;&#245;es mediadas pela IgE&#44; nos mast&#243;citos e bas&#243;filos&#44; n&#227;o s&#227;o cruciais ao combate de infec&#231;&#245;es virais&#46;</p><p id="par0070" class="elsevierStylePara elsevierViewall">Apenas tr&#234;s pacientes &#40;6&#44;25&#37;&#41; mencionaram rea&#231;&#227;o cut&#226;nea no local da aplica&#231;&#227;o da vacina&#46; A frequ&#234;ncia desse evento &#233; de 4&#37; na popula&#231;&#227;o que recebe a VFA&#46;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">6</span></a> Um indiv&#237;duo &#40;2&#44;08&#37;&#41; referiu astenia&#46; A ocorr&#234;ncia de manifesta&#231;&#227;o sist&#234;mica &#233; de 1&#37; a 6&#37; dos indiv&#237;duos&#46; Por fim&#44; um paciente &#40;2&#44;08&#37;&#41; referiu exacerba&#231;&#227;o do angioedema ao tomar a vacina&#44; o que pode estar ligado tanto a uma poss&#237;vel rea&#231;&#227;o &#224; VFA quanto &#224; flutua&#231;&#227;o na atividade do controle da urtic&#225;ria em tratamento&#46;</p><p id="par0075" class="elsevierStylePara elsevierViewall">Comparando&#8208;se os grupos doentes em uso do omalizumabe que tomaram a VFA e doentes com UC sem omalizumabe que tomaram a VFA&#44; n&#227;o houve diferen&#231;a estat&#237;stica&#46; No grupo controle das 30 pessoas sadias comparando&#8208;se aos 30 doentes com UC que faziam uso do omalizumabe e tomaram a VFA tamb&#233;m n&#227;o se observou diferen&#231;a estat&#237;stica em rela&#231;&#227;o aos efeitos adversos&#46;</p><p id="par0080" class="elsevierStylePara elsevierViewall">Nosso estudo mostrou que os doentes com UC em tratamento com anti&#8208;histam&#237;nicos e&#47;ou omalizumabe n&#227;o referiram eventos adversos ap&#243;s a imuniza&#231;&#227;o contra a FA&#44; quando comparados aos indiv&#237;duos sadios&#44; sem UC&#44; que receberam a imuniza&#231;&#227;o no mesmo per&#237;odo&#44; com a mesma vacina fornecida pelo Minist&#233;rio da Sa&#250;de do Brasil&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0005">Suporte financeiro</span><p id="par0085" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Contribui&#231;&#227;o dos autores</span><p id="par0090" class="elsevierStylePara elsevierViewall">Laura Ramos de Almeida&#58; An&#225;lise estat&#237;stica&#59; elabora&#231;&#227;o e reda&#231;&#227;o do manuscrito&#59; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#46;</p><p id="par0095" class="elsevierStylePara elsevierViewall">Roberta Fachini Criado&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; participa&#231;&#227;o efetiva na orienta&#231;&#227;o da pesquisa&#46;</p><p id="par0100" class="elsevierStylePara elsevierViewall">Paulo Ricardo Criado&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; participa&#231;&#227;o efetiva na orienta&#231;&#227;o da pesquisa&#46;</p><p id="par0105" class="elsevierStylePara elsevierViewall">Luis Felipe Ensina&#58; An&#225;lise estat&#237;stica&#59; aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; revis&#227;o cr&#237;tica da literatura&#46;</p><p id="par0110" class="elsevierStylePara elsevierViewall">Beatrice Martinez Zugaib Abdalla&#58; Aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; elabora&#231;&#227;o e reda&#231;&#227;o do manuscrito&#59; obten&#231;&#227;o&#44; an&#225;lise e interpreta&#231;&#227;o dos dados&#59; revis&#227;o cr&#237;tica da literatura&#46;</p><p id="par0115" class="elsevierStylePara elsevierViewall">Juarez Ant&#244;nio Sim&#245;es Quaresma&#58; An&#225;lise estat&#237;stica&#59; aprova&#231;&#227;o da vers&#227;o final do manuscrito&#59; concep&#231;&#227;o e planejamento do estudo&#59; revis&#227;o cr&#237;tica da literatura&#46;</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Conflito de interesses</span><p id="par0120" class="elsevierStylePara elsevierViewall">Nenhum&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:4 [
        0 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "Suporte financeiro"
        ]
        1 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Contribui&#231;&#227;o dos autores"
        ]
        2 => array:2 [
          "identificador" => "sec0015"
          "titulo" => "Conflito de interesses"
        ]
        3 => array:1 [
          "titulo" => "Refer&#234;ncias"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2020-06-14"
    "fechaAceptado" => "2020-09-03"
    "NotaPie" => array:2 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Como citar este artigo&#58; Almeida LR&#44; Criado RF&#44; Criado PR&#44; Ensina LF&#44; Abdalla BMZ&#44; Quaresma JAS&#46; Adverse events of the yellow fever vaccine in chronic urticaria&#58; evaluation of patients treated or not with omalizumab compared to healthy individuals&#46; An Bras Dermatol&#46; 2021&#59;96&#58;497&#8211;9&#46;</p>"
      ]
      1 => array:2 [
        "etiqueta" => "&#9734;&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Trabalho realizado na Faculdade de Medicina do ABC&#44; Santo Andr&#233;&#44; SP&#44; Brasil&#46;</p>"
      ]
    ]
    "multimedia" => array:3 [
      0 => array:7 [
        "identificador" => "fig0005"
        "etiqueta" => "Figura 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 2003
            "Ancho" => 2917
            "Tamanyo" => 347327
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Fluxograma da coleta de dados de doentes com urtic&#225;ria cr&#244;nica imunizados e n&#227;o imunizados com a vacina da febre amarela e indiv&#237;duos sadios imunizados com a mesma vacina&#46;</p>"
        ]
      ]
      1 => array:8 [
        "identificador" => "tbl0005"
        "etiqueta" => "Tabela 1"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at1"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:2 [
          "leyenda" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">UC&#44; urtic&#225;ria cr&#244;nica&#46;</p>"
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Caracter&#237;sticas dos doentes&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Frequ&#234;ncia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&#37;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">G&#234;nero</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Masculino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16&#44;85&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Feminino&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">74&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">83&#44;15&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Classifica&#231;&#227;o da urtic&#225;ria</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCE&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">71&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">79&#44;78&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCindu&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">4&#44;49&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UCE &#43; UCind&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">14&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">15&#44;73&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Manifesta&#231;&#245;es cl&#237;nicas</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UC &#43; angiodema&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">63&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">70&#44;79&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>UC isolado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">28&#44;09&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Angiodema isolado&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1&#44;12&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Uso de omalizumabe</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>N&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">35&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">39&#44;33&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Sim&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">54&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0&#44;67&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleVsp" style="height:0.5px"></span></td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " colspan="3" align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleItalic">Tomou a vacina de febre amarela&#63;</span></td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>N&#227;o&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">41&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">46&#44;07&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Sim&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">48&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">53&#44;93&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2658516.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Dados demogr&#225;ficos&#44; tipo de urtic&#225;ria&#44; uso do omalizumabe e imuniza&#231;&#227;o contra a febre amarela entre os 89 doentes com urtic&#225;ria participantes do estudo</p>"
        ]
      ]
      2 => array:8 [
        "identificador" => "tbl0010"
        "etiqueta" => "Tabela 2"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "detalles" => array:1 [
          0 => array:3 [
            "identificador" => "at2"
            "detalle" => "Tabela "
            "rol" => "short"
          ]
        ]
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td-with-role" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">Grupos de indiv&#237;duos&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " colspan="5" align="center" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rea&#231;&#245;es adversas atribu&#237;das &#224; vacina contra febre amarela</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Nenhuma&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Rea&#231;&#227;o cut&#226;nea local&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Astenia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Exacerba&#231;&#227;o do angioedema&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Febre&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t" scope="col" style="border-bottom: 2px solid black">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo A&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">25 &#40;83&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">3 &#40;10&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;6&#44;67&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo B&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">27 &#40;90&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;3&#44;33&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">30 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Grupo C&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">16 &#40;88&#44;89&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;11&#44;11&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">0 &#40;0&#44;0&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">18 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">Total&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">68 &#40;87&#44;18&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">6 &#40;7&#44;69&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;1&#44;28&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">1 &#40;1&#44;28&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">2 &#40;2&#44;56&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="\n
                  \t\t\t\t\ttop\n
                  \t\t\t\t">78 &#40;100&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2658515.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "pt" => "<p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Compara&#231;&#227;o entre o relato de rea&#231;&#245;es adversas atribu&#237;das &#224; vacina&#231;&#227;o contra a febre amarela&#44; entre indiv&#237;duos sadios &#40;grupo A&#41;&#44; doentes com urtic&#225;ria cr&#244;nica tratados com omalizumabe &#40;grupo B&#41; doentes com urtic&#225;ria cr&#244;nica sem uso de omalizumabe &#40;grupo C&#41;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Refer&#234;ncias"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0015"
          "bibliografiaReferencia" => array:6 [
            0 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => """
                    Brasil&#46; Minist&#233;rio da Sa&#250;de&#46; Minist&#233;rio da Sa&#250;de divulga balan&#231;o de um ano da febre amarela &#91;Internet&#93;&#46; 2018 Dez&#46; 8 &#91;cited 2018 Dez 27&#93;&#46; Dispon&#237;vel em&#58; \n
                    <https: www.gov.br="" aude="" t&#8208;br="" ssuntos="" oticias="" inisterio&#8208;da&#8208;saude&#8208;divulga&#8208;balanco&#8208;de&#8208;um&#8208;ano&#8208;da&#8208;febre&#8208;amarela="">\n
                     &#46;\n
                    </https:>
                    """
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "2"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Chronic urticaria in adults&#58; state&#8208;of&#8208;the&#8208;art in the new millennium"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "P&#46;R&#46; Criado"
                            1 => "R&#46;F&#46;J&#46; Criado"
                            2 => "C&#46;W&#46; Maruta"
                            3 => "V&#46;M&#46;S&#46; Reis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1590/abd1806-4841.20153509"
                      "Revista" => array:6 [
                        "tituloSerie" => "An Bras Dermatol&#46;"
                        "fecha" => "2015"
                        "volumen" => "90"
                        "paginaInicial" => "74"
                        "paginaFinal" => "89"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25672302"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "3"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => "Sociedade Brasileira de Infectologia&#46; &#91;Internet&#93;&#46; Vacina contra febre amarela informativo para profissionais de sa&#250;de &#91;Internet&#93;&#46; 2018 Jan 30 &#91;cited 2019 Jan 3&#93;&#46; Dispon&#237;vel em&#58; www&#46;infectologia&#46;org&#46;br&#46;"
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "4"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Fractional&#8208;dose yellow fever vaccination&#58; how much more can we do with less&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "L&#46;G&#46; Visser"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1097/QCO.0000000000000576"
                      "Revista" => array:6 [
                        "tituloSerie" => "Curr Opin Infect Dis&#46;"
                        "fecha" => "2019"
                        "volumen" => "32"
                        "paginaInicial" => "390"
                        "paginaFinal" => "393"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/31335440"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "5"
              "referencia" => array:1 [
                0 => array:1 [
                  "referenciaCompleta" => """
                    Brasil&#46; Minist&#233;rio da Sa&#250;de&#46; Contraindica&#231;&#245;es para a Vacina de Febre Amarela &#91;Internet&#93;&#46; &#91;cited 2019 Mar 23&#93;&#46; Dispon&#237;vel em&#58; \n
                    <www.saude.gov.br>\n
                     &#46;\n
                    </www.saude.gov.br>
                    """
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "6"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Serious adverse events associated with yellow fever vaccine"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "R&#46; Menezes Martins"
                            1 => "M&#46;L&#46; Fernandes Leal"
                            2 => "A&#46; Homma"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1080/21645515.2015.1022700"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hum Vaccin Immunother&#46;"
                        "fecha" => "2015"
                        "volumen" => "11"
                        "paginaInicial" => "2183"
                        "paginaFinal" => "2187"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/26090855"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "pt"
  "url" => "/26662752/0000009600000004/v1_202107170646/S266627522100120X/v1_202107170646/pt/main.assets"
  "Apartado" => array:4 [
    "identificador" => "82068"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Carta - Investiga&#231;&#227;o"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/26662752/0000009600000004/v1_202107170646/S266627522100120X/v1_202107170646/pt/main.pdf?idApp=UINPBA00008Z&text.app=https://clinics.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S266627522100120X?idApp=UINPBA00008Z"
]
Informação do artigo
ISSN: 26662752
Idioma original: Português
Dados atualizados diariamente
Ano/Mês Html Pdf Total
2024 Novembro 17 8 25
2024 Outubro 124 71 195
2024 Setembro 133 83 216
2024 Agosto 170 127 297
2024 Julho 145 106 251
2024 Junho 119 69 188
2024 Maio 82 68 150
2024 Abril 110 78 188
2024 Março 122 68 190
2024 Fevereiro 161 72 233
2024 Janeiro 119 50 169
2023 Dezembro 71 50 121
2023 Novembro 91 89 180
2023 Outubro 81 60 141
2023 Setembro 96 71 167
2023 Agosto 90 24 114
2023 Julho 105 26 131
2023 Junho 69 37 106
2023 Maio 69 28 97
2023 Abril 62 19 81
2023 Março 89 38 127
2023 Fevereiro 77 31 108
2023 Janeiro 55 38 93
2022 Dezembro 69 22 91
2022 Novembro 94 64 158
2022 Outubro 117 53 170
2022 Setembro 65 62 127
2022 Agosto 72 53 125
2022 Julho 54 52 106
2022 Junho 54 55 109
2022 Maio 41 51 92
2022 Abril 62 44 106
2022 Março 60 75 135
2022 Fevereiro 42 46 88
2022 Janeiro 81 97 178
2021 Dezembro 51 62 113
2021 Novembro 48 79 127
2021 Outubro 68 115 183
2021 Setembro 67 82 149
2021 Agosto 98 105 203
2021 Julho 79 61 140
2021 Junho 28 35 63
Mostrar tudo

Siga este link para acessar o texto completo do artigo

Idiomas
Anais Brasileiros de Dermatologia (Portuguese)
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.